Acurx Pharmaceuticals Valuation
| ACXP Stock | USD 0.43 0.01 2.38% |
Acurx Pharmaceuticals is undervalued. Acurx Pharmaceuticals LLC shows a prevailing Real Value of $3.12 per share. The current price of the firm is $0.43. Our model approximates the value of Acurx Pharmaceuticals LLC from analyzing the firm fundamentals such as Return On Equity of -5.34, current valuation of 5.79 M, and Shares Owned By Insiders of 11.66 % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Acurx Pharmaceuticals' valuation include:
Undervalued
Today
Please note that Acurx Pharmaceuticals' price fluctuation is dangerous at this time. Calculation of the real value of Acurx Pharmaceuticals LLC is based on 3 months time horizon. Increasing Acurx Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Acurx Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0.43, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 3.12 | Target 11.19 | Hype 0.38 |
The intrinsic value of Acurx Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Acurx Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Acurx Pharmaceuticals LLC helps investors to forecast how Acurx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Acurx Pharmaceuticals more accurately as focusing exclusively on Acurx Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Acurx Pharmaceuticals' intrinsic value based on its ongoing forecasts of Acurx Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Acurx Pharmaceuticals' closest peers.
Acurx Pharmaceuticals Cash |
|
Acurx Valuation Trend
Acurx Pharmaceuticals' real value is important for investors to make better decisions and a more accurate overall view of Acurx Pharmaceuticals' financial worth over time. Using both Acurx Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Acurx Pharmaceuticals Total Value Analysis
Acurx Pharmaceuticals LLC is presently anticipated to have valuation of 5.79 M with market capitalization of 9.5 M, debt of 3.24 B, and cash on hands of 9.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Acurx Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.79 M | 9.5 M | 3.24 B | 9.09 M |
Acurx Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Acurx is to check how much profit was generated for every dollar of assets it reports. Acurx Pharmaceuticals LLC shows a negative utilization of assets of -1.52 percent, losing $0.0152 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Acurx Pharmaceuticals LLC shows how discouraging it operates for each dollar spent on its assets.Acurx Pharmaceuticals Ownership Allocation
Acurx Pharmaceuticals holds a total of 22.04 Million outstanding shares. Acurx Pharmaceuticals LLC shows 11.66 percent of its outstanding shares held by insiders and 9.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Acurx Pharmaceuticals Profitability Analysis
Net Loss for the year was (14.1 B) with profit before overhead, payroll, taxes, and interest of 0.About Acurx Pharmaceuticals Valuation
The stock valuation mechanism determines Acurx Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Acurx Pharmaceuticals LLC based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acurx Pharmaceuticals. We calculate exposure to Acurx Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Acurx Pharmaceuticals's related companies.Acurx Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Acurx Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 16.2 M |
Acurx Pharmaceuticals Current Valuation Indicators
Acurx Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Acurx Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Acurx Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Acurx Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Acurx Pharmaceuticals' worth.Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.